Takehiko Yokobori

27PUBLICATIONS
42CO-AUTHORS
Cancer diagnosisInnate immunityPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 25, 2026
Extrachromosomal Circular DNA May Contribute to Histopathologic Characteristics in Esophageal Combined Basaloid Squamous Cell Carcinoma.

|Sep 02, 2026
CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

|Jul 17, 2026
High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression.

|Feb 27, 2026
Smaller Oxygen Nanobubbles More Effectively Suppress Colitis and Colon Carcinogenesis than Larger Oxygen Nanobubbles.

Gendensuren Dorjkhorloo, Haruka Okami, Nobutoshi Mutsuki

|Jan 10, 2026
Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil.

Makoto Sakai, Nobuhiro Nakazawa, Kengo Kuriyama

|Sep 30, 2025
Novel therapeutic strategy targeting STMN1 using chlorambucil-conjugated pyrrole-imidazole polyamide in small cell lung cancer.

Ryohei Yoshikawa, Takayoshi Watanabe, Yoichi Ohtaki

Pageof 5

Frequent Collaborators

5 joint publications

Nobuhiro Nakazawa

4 joint publications

Makoto Sakai

3 joint publications

Navchaa Gombodorj

2 joint publications

Hiroshi Saeki